Frequent amplification of SETDB1 in various tumor types (including melanoma, lung, colon, breast and liver cancers (12–16)) and SETDB1 deletion-associated defects in tumor growth support its function as a prominent cancer driver (17). This evidence concerns the gene SETDB1 and neoplasm.